Considering Radiation and Preoperative Therapy Options in Locally Advanced GEJ Cancers
Weijing Sun, MD, discusses a major topic in locally advanced gastroesophageal junction adenocarcinoma covered at the 2018 ISGIO Annual Conference in Arlington, Virginia.
Weijing Sun, MD, gastrointestinal oncologist at the University of Kansas School of Medicine, discusses a major topic in locally advanced gastroesophageal junction (GEJ) adenocarcinoma covered at the 2018 ISGIO Annual Conference in Arlington, Virginia.
At the conference, experts debated the role of radiation therapy in this patient population, Sun says. Two studies looked at different preoperative therapy options with encouraging data both with and without radiation.
The FLOT study explored a regimen of fluorouracil, leucovorin, oxaliplatin, and docetaxel for this patient population, without radiation. The CROSS study looked at the combination of carboplatin and paclitaxel with radiation.
Ilson Examines Chemoimmunotherapy Regimens for Metastatic Gastroesophageal Cancers
December 20th 2024During a Case-Based Roundtable® event, David H. Ilson, MD, PhD, discussed the outcomes of the CheckMate 649, CheckMate 648, and KEYNOTE-859 trials of chemoimmunotherapy regimens in patients with upper GI cancers.
Read More
ctDNA Detection Tied to Tumor Burden, Recurrence in HR+ Early Breast Cancer
December 13th 2024A phase 2 trial showed ctDNA detection in HR-positive early breast cancer was linked to larger tumors, higher residual cancer burden, and increased recurrence after neoadjuvant endocrine therapy.
Read More
